Clinical Trial Update: Evaluation of the Efficacy and Safety of Insulin Glargine 300 U/mL in Patients With Type 2 Diabetes Mellitus Uncontrolled on Other Kinds of Insulin [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the efficacy and safety of insulin glargine 300 U/mL in adults with type 2 diabetes mellitus inadequately controlled on other insulins.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• insulin glargine 300 U/mL (insulin glargine)

Snippet

Sponsor: Sanofi | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: COMPLETED